BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29037445)

  • 1. Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation.
    Muslem R; Caliskan K; Akin S; Yasar YE; Sharma K; Gilotra NA; Kardys I; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Manintveld OC; Russell SD
    Am J Cardiol; 2017 Dec; 120(12):2221-2225. PubMed ID: 29037445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Topkara VK; Coromilas EJ; Garan AR; Li RC; Castagna F; Jennings DL; Yuzefpolskaya M; Takeda K; Takayama H; Sladen RN; Mancini DM; Naka Y; Radhakrishnan J; Colombo PC
    Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27932533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening Renal Function in Cardiac Mechanical Support.
    Tsay J; Pinkhas D; Lee BC; Guo A; Ferrall J; Derbala MH; Lampert BC; Emani S; Whitson BA; Smith SA
    Heart Lung Circ; 2020 Aug; 29(8):1247-1255. PubMed ID: 32088146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency.
    Pasrija C; Tran D; George P; Sorensen E; Kaczorowski DJ; Ton VK; Kon ZN;
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1307-1319.e2. PubMed ID: 31128896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial changes in renal function as a prognostic indicator in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Ann Thorac Surg; 2012 Mar; 93(3):816-23. PubMed ID: 22364976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury and 1-year mortality after left ventricular assist device implantation.
    Muslem R; Caliskan K; Akin S; Sharma K; Gilotra NA; Constantinescu AA; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Russell SD; Manintveld OC
    J Heart Lung Transplant; 2018 Jan; 37(1):116-123. PubMed ID: 29174532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Givertz MM; Young JB
    J Heart Lung Transplant; 2013 Dec; 32(12):1205-13. PubMed ID: 24119728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
    Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative proteinuria in left ventricular assist devices and clinical outcome.
    Muslem R; Caliskan K; Akin S; Sharma K; Gilotra NA; Brugts JJ; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Manintveld OC; Russell SD
    J Heart Lung Transplant; 2018 Jan; 37(1):124-130. PubMed ID: 28781011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.
    Atluri P; Goldstone AB; Kobrin DM; Cohen JE; MacArthur JW; Howard JL; Jessup ML; Rame JE; Acker MA; Woo YJ
    Ann Thorac Surg; 2013 Jul; 96(1):141-7. PubMed ID: 23731606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ventricular assist device placement on longitudinal renal function in children with end-stage heart failure.
    May LJ; Montez-Rath ME; Yeh J; Axelrod DM; Chen S; Maeda K; Almond CS; Rosenthal DN; Hollander SA; Sutherland SM
    J Heart Lung Transplant; 2016 Apr; 35(4):449-56. PubMed ID: 26653933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.